PedAM
Pediatric Disease Annotations & Medicines
| Disease | thrombocytopenia |
| Phenotype | C0023890|liver cirrhosis |
| Sentences | 9 |
| PubMedID- 22588242 | Coated transjugular intrahepatic portosystemic shunt does not improve thrombocytopenia in patients with liver cirrhosis. |
| PubMedID- 20405675 | In consequence, numerous procedures were imagined to reverse thrombocytopenia associated with liver cirrhosis, among wich splenectomy. |
| PubMedID- 20337100 | [splenomegaly and thrombocytopenia in patients with liver cirrhosis]. |
| PubMedID- 24815053 | thrombocytopenia associated with liver cirrhosis was the most represented etiology. |
| PubMedID- 24466297 | The anti-gpiib/iiia antibody response is very common in patients with primary itp as well as those with various forms of secondary itp, including thrombocytopenia associated with sle [8], liver cirrhosis with or without hypersplenism [9], and post-hematopoietic stem-cell transplantation (post-hsct) [10]. |
| PubMedID- 24627595 | Of these factors, the major mechanisms for thrombocytopenia in liver cirrhosis are (1) platelet sequestration in the spleen; and (2) decreased production of thrombopoietin in the liver. |
| PubMedID- 24137205 | At present, the suggestion is that hypersplenism, decreased thrombopoietin (tpo) synthesis and bone suppression result in thrombocytopenia in patients with liver cirrhosis (20–23). |
| PubMedID- 23467038 | Although the patient usually showed thrombocytopenia associated with liver cirrhosis, an increase in her platelet count was observed (27.6 × 104/μl). |
| PubMedID- 26002134 | Partial splenic embolization for thrombocytopenia in liver cirrhosis: predictive factors for platelet increment and risk factors for major complications. |
Page: 1